Neither the presence of hyperprolactinemia nor the positive immunohistochemical staining for prolactin was related to the reduction in IGF-1 or the rate of disease control, supposing that presence of PRL expression might not predict the response. This evidence concerns the gene PRL and hyperprolactinemia.